4DMT
4DMT’s Gene Therapy Reduces Eylea Injections, Advancing Plans for Phase 3 Trial in Wet AMD
Glycogen storage disease type II, 4DMT, gene therapy, Trial Phase
Actionable Insights Powered by AI
Glycogen storage disease type II, 4DMT, gene therapy, Trial Phase